Characterisation of the novel MICA*112:02 allele by next generation sequencing
HLA · 2024
DOI: 10.1111/tan.15583 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Milena Ivanova und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Alexandrovska University Hospital, Medical University Sofia, Sofia, Bulgaria. Hauptthemen laut MEDLINE: High-Throughput Nucleotide Sequencing, Alleles, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 4 Literaturangaben. Gefördert von: Bulgarian National Science Fund (BNSF), Ministry of Education and Science (MES) of Bulgaria, Bulgarian National Science Fund.
Abstract (Originalsprache)
The novel MICA*112:02 allele was detected by next generation sequencing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Immunology, Alexandrovska University Hospital, Medical University Sofia, Sofia, Bulgaria.
- Department of Experimental Research, Medical University Pleven, Pleven, Bulgaria.
ORCID-Profile: Milena Ivanova, Velizar Shivarov
Förderung
- Bulgarian National Science Fund (BNSF), Ministry of Education and Science (MES) of Bulgaria
- Bulgarian National Science Fund
Zitieren
APA
Ivanova, M., & Shivarov, V. (2024). Characterisation of the novel MICA*112:02 allele by next generation sequencing. HLA. https://doi.org/10.1111/tan.15583
Vancouver
Ivanova M, Shivarov V. Characterisation of the novel MICA*112:02 allele by next generation sequencing. HLA. 2024. doi:10.1111/tan.15583
BibTeX
@article{Ivanova2024,
author = {Ivanova, Milena and Shivarov, Velizar},
title = {Characterisation of the novel MICA*112:02 allele by next generation sequencing},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15583}
}
EUVIMED